FECINOR
LIVE

Serial Number

79221914

Owner

EVONIK OPERATIONS GMBH

Filing Date

May 23, 2017

Add to watchlist:

No watchlists yet
View on USPTO

FECINOR Trademark

Serial Number: 79221914 • Registration: 5753865

FECINOR is a trademark filed by EVONIK OPERATIONS GMBH on May 23, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 31 (Natural Agricultural Products). The application is currently registered and active.

Owner Contact Info

EVONIK OPERATIONS GMBH (467 trademarks)

RELLINGHAUSER STRASSE 1-11
ESSEN 45128 , DE

Entity Type: 16

EVONIK DEGUSSA GMBH (447 trademarks)

RELLINGHAUSER STRASSE 1-11,
ESSEN 45128 , DE

Entity Type: 16

Trademark Details

Filing Date

May 23, 2017

Registration Date

May 21, 2019

Published for Opposition

March 5, 2019

Cancellation Date

December 5, 2025

Goods & Services

Agricultural, horticultural and forestry products as well as products for aquaculture, namely, aquaculture feed; live animals; organisms for breeding, namely, live animals; foodstuffs and fodder for animals; bedding for animals, namely, chopped straw for animal bedding, cellulose for use as animal bedding, and litter for animals; animal feed preparations; nutrients foodstuffs for fish and aquacultures, namely, aquaculture feed, foodstuffs for fish; yeast for animal consumption

Pharmaceutical and veterinary preparations for the prevention and for the treatment of nutrition deficiencies, intestinal health, digestive health and stomach disorders; pharmaceutical and veterinary preparations for the prevention and treatment of bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; pharmaceutical and veterinary preparations for the prevention and treatment of necrotic enteritis; diarrhea medication; pharmaceutical and veterinary preparations for the prevention and treatment of intestinal bacteria; pharmaceutical and veterinary preparations for the prevention and for the treatment of nutrition deficiencies, intestinal health, digestive health and stomach disorders containing Enterococcus faecium; veterinary pharmaceutical preparations for the prevention and for the treatment of probiotic deficiencies; veterinary preparations, namely, feeding stimulants for animals; medical and veterinary preparations for the prevention and for the treatment of nutrition deficiencies, intestinal health, digestive health and stomach disorders; medical and veterinary preparations for the prevention and for the treatment of bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; medical and veterinary preparations, namely, fodder acidifiers for medical purposes and fodder additives for medical purposes in form of amino acids, peptides and proteins and mixtures thereof; medical and veterinary preparations for the prevention and for the treatment of necrotic enteritis; medical and veterinary preparations for the prevention and for the treatment of intestinal bacteria; medical and veterinary preparations for the prevention and for the treatment of nutrition deficiencies, intestinal health, digestive health and stomach disorders containing Enterococcus faecium; chemical preparations for medical, pharmaceutical and veterinary purposes for the prevention and for the treatment of nutrition deficiencies, intestinal health, digestive health and stomach disorders; chemical preparations for medical, pharmaceutical and veterinary purposes for the prevention and for the treatment bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; chemical preparations for medical, pharmaceutical and veterinary purposes for the prevention and for the treatment of necrotic enteritis; chemical preparations for medical, pharmaceutical and veterinary purposes for the prevention and for the treatment of intestinal bacteria; amino acids for medical and veterinary purposes; chemical preparations in the nature of esters, medicinal oils and greases for medical and veterinary purposes; salts, in particular potassium and sodium salts for medical purposes; salts, in particular potassium and sodium salts for veterinary medical purposes; steroids; ferments for pharmaceutical purposes; dietetic foods, namely, yeast and starch for medical purposes; yeast and starch for pharmaceutical purposes; enzymes and enzyme preparations for medical and veterinary purposes; biological preparations for medical and veterinary purposes, namely, for the prevention and for the treatment of nutrition deficiencies, intestinal health, digestive health and stomach disorders; bacteriological preparations for medical and veterinary purposes; cultures of microorganisms for medical and veterinary use; nutritive substances for microorganisms for medical purposes; bouillons for bacteriological cultures; dietetic food and substances adapted for medical or veterinary use; albuminous preparations for medical purposes, namely, albumin dietary supplements; medicated confectionery in the nature of medicated candy; medicinal drinks; dietetic beverages adapted for medical purposes; medical preparations for slimming purposes; food for babies; nutritional supplements for humans; dietary supplements for animals; sugar, in particular candy and glucose for medical purposes; glucose for medical purposes; protein dietary supplements; mineral food supplements; preparations of trace elements for human and animal use, namely, dietary supplements; vitamin preparations; animal feed supplements, not for medical purposes; animal feed supplements in form of amino acids, peptides and proteins for animal feed, fish food and aquacultures; animal feed supplements, namely, non-medicated additives for animal feed for use as nutritional supplements; probiotic supplements; probiotic animal feed; nutritional supplements, namely, probiotic compositions; micro-nutrient animal feed for fish and aquacultures; feed supplements, namely, synthetic peptides for the treatment of nutrition deficiencies; protein supplements for animals; amino acids and peptides for nutritional purposes for use in animal feed, fish food and aquaculture; feed supplements containing Enterococcus faecium

Filing History

CANCELLED SECTION 71
Dec 5, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 21, 2024 REM3
CHANGE OF OWNER RECEIVED FROM IB
Aug 5, 2022 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 27, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 10, 2019 FICS
FINAL DISPOSITION PROCESSED
Sep 10, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 21, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
May 21, 2019 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 17, 2019 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 1, 2019 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 1, 2019 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 5, 2019 NPUB
PUBLISHED FOR OPPOSITION
Mar 5, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Mar 1, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 13, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 13, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 13, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 28, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 28, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 28, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 18, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 21, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jul 21, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jul 21, 2018 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 29, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 29, 2018 CRFA
ASSIGNED TO LIE
Jun 28, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 13, 2018 TROA
REFUSAL PROCESSED BY IB
Jan 19, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 27, 2017 RFCS
REFUSAL PROCESSED BY MPU
Dec 27, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 13, 2017 RFCR
NON-FINAL ACTION WRITTEN
Dec 12, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Dec 12, 2017 MAFR
ASSIGNED TO EXAMINER
Dec 8, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 8, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 30, 2017 REPR